NWBO
Northwest Biotherapeutics, Inc. Common stock
NWBO
NWBO
Delisted
NWBO was delisted on the 16th of December, 2016.
27 hedge funds and large institutions have $16.8M invested in Northwest Biotherapeutics, Inc. Common stock in 2013 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
16% more call options, than puts
Call options by funds: $135K | Put options by funds: $116K
Holders
27
Holding in Top 10
–
Calls
$135K
Puts
$116K
Top Buyers
| 1 | +$7.28M | |
| 2 | +$1.37M | |
| 3 | +$361K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$212K |
| 5 |
CL
Croft-Leominster
Baltimore,
Maryland
|
+$114K |
Top Sellers
| 1 | -$1.61M | |
| 2 | -$124K | |
| 3 | -$87K | |
| 4 |
KA
Kovack Advisors
Ft. Lauderdale,
Florida
|
-$14.3K |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$1 |